↗
investz
Investing, A to Z
Markets
News
Research
Screener
Sectors
Learn
Watchlists
Portfolio
Books
Audio
☀
S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,486.06
▲ +106.09 (+0.13%)
--:--:--
NYSE · Live ET
ORIC (ORIC)
13.17
-0.46 (-3.37%)
USD · · delayed · updates about every minute
☆ Add to watchlist
Key statistics
Previous close
13.63
Day range
12.73 – 13.49
52-week low
7.23
52-week high
14.68
Volume
—
Type
—
52-WEEK RANGE POSITION
ORIC news
Simply Wall Street
ORIC Pharmaceuticals (ORIC) Could Be 36% Undervalued On New ESMO Data And Phase 3 Plans
3h ago
Yahoo Finance UK
ORIC Pharmaceuticals, Inc. (ORIC) stock price, news, quote and history
11h ago
Simply Wall Street
How Investors May Respond To ORIC Pharmaceuticals (ORIC) Phase 3 Trial Plans
1d ago
MarketBeat
Oric Pharmaceuticals, Inc. (ORIC) - What Are Analysts Thinking About This Stock?
2d ago
Stock Traders Daily
Trading Systems Reacting to (ORIC) Volatility
2d ago
TradingView
Oric Pharmaceuticals, Inc. Estimates – NASDAQ:ORIC
2d ago
Traders Union
Oric Pharmaceuticals moves enozertinib into Phase 3 trial: Will ORIC hold the MA-50?
2d ago
Yahoo Finance
Oric Pharmaceuticals’ Enozertinib Shows 88% Response Rate in EGFR Lung Cancer Study
2d ago
Learn to invest
The Psychology of Money
Morgan Housel ·
Beginner
The Little Book of Common Sense Investing
John C. Bogle ·
Beginner
The Intelligent Investor
Benjamin Graham ·
Intermediate